04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 01189/KOLNP/2005 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 21/06/2005 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE<br />

INHIBITORES AND THEIR USE IN THE TREATMENT OF CANCER<br />

(51) International classification : C07D 401/12,<br />

407/14, 403/12,<br />

407/12, 239/48,<br />

417/12, 403/04,<br />

403/14, 401/14,<br />

A61K 31/506,<br />

A61P 35/00<br />

(31) Priority Document No : 60/428,473<br />

60/438,568<br />

60/523,081<br />

(32) Priority Date : 21/11/2002<br />

07/012003<br />

19/11/2003<br />

(33) Name <strong>of</strong> priority country : US<br />

(86) International Application No and : PCT/US03/037294<br />

Filing Date<br />

: & 21/11/2003<br />

(87) International Publication No : WO 04/048365<br />

(61) Patent <strong>of</strong> addition to Application No : NA<br />

Filed on : NA<br />

(62) Divisional to Application No : NA<br />

Filed on : NA<br />

(57) Abstract:<br />

Compounds having formula I are provided where <strong>the</strong> variables have<br />

<strong>the</strong> values described herein. (I). Pharmaceutical formulations include<br />

<strong>the</strong> compounds or pharmaceutically acceptable salts <strong>the</strong>re<strong>of</strong> and a<br />

pharmaceutically acceptable carrier and combinations with o<strong>the</strong>r<br />

agents. A method <strong>of</strong> treating a patient comprises administering a<br />

pharmaceutical formulation according to <strong>the</strong> invention to a patient in<br />

need <strong>the</strong>re<strong>of</strong>.<br />

(FIG). Nil<br />

(71) Name <strong>of</strong> Applicant:<br />

CHIRON CORPORATION.,<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

4-38 MINATO-MACHI, 1-CHOME, NANIWA-KU,<br />

OSAKA-SHI, OSAKA 556-0017, JAPAN.4560<br />

HORTON STREET, EMERYVILLE, CA 94608-<br />

2916, USA.<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

1) NUSS, JOHN, M.<br />

2) PECCHI, SABINA<br />

3) RENHOWE, PAUL, A<br />

Filed U/S 5(2) before The <strong>Patents</strong> (Amendment)<br />

Act, 2005: NO<br />

The Patent Office Journal 09/06/2006 11080

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!